Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com
Secteur(s): Healthcare
Secteur d’activité: Medical Distribution
Employés à temps plein: 47 811
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Bo Shen | Pres, CFO, Head of the Accounting Department & Exec. Director | 797,01k | S.O. | 1973 |
Mr. Yongzhong Li | VP & Exec. Director | 896,25k | S.O. | 1970 |
Mr. Tao Zhong | VP, Board Sec. & Joint Company Sec. | S.O. | S.O. | 1972 |
Mr. Dongming Li | VP | S.O. | S.O. | 1969 |
Ms. Shuai Shao | VP | S.O. | S.O. | 1988 |
Dr. Shunjiang Yu | Chief Medical Officer | S.O. | S.O. | S.O. |
Mr. Ming Dong | Exec. Director | S.O. | S.O. | 1976 |
Ms. Shui Bing Leung A.C.S. | Joint Company Sec. | S.O. | S.O. | 1977 |
Ying Ke | Director & Gen. Mang. of R&D Management Center | S.O. | S.O. | S.O. |
Linqiong Dong | Securities Affairs Representative | S.O. | S.O. | S.O. |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
L’ISS Governance QualityScore de Shanghai Pharmaceuticals Holding Co., Ltd en date du 1 septembre 2023 est 8. Les scores principaux sont Audit : 6; Société : 10; Droits des actionnaires : 9; Compensation : 1.